Prucalopride Tablet, Film Coated
Product Images NDC 69097-219

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prucalopride (NDC 69097-219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Prucalopride Structure (Prucalopride Structure)

Chemical structure of prucalopride as depicted in the image, illustrating the arrangement of its molecular components and bonds.*

FDA Label Image

Prucalopride_1mg Label (Prucalopride 1mg Label)

Prucalopride 1 mg film-coated tablets packaging label. The label indicates a prescription drug with 30 tablets per bottle, manufactured by Zenara Pharma Private Limited and labeled by Cipla USA Inc. It includes storage instructions and the NDC 69097-218-02, emphasizing the 1 mg strength prominently.*

FDA Label Image

Prucalopride_2 mg Label (Prucalopride 2 mg Label)

Label for Prucalopride 2 mg tablets, film coated, oral use, manufactured for Cipla USA Inc. The carton holds 30 tablets. The label includes storage instructions, dosage guidance of one tablet once daily, and manufacturer information citing Zenara Pharma Private Limited, Hyderabad, India. Barcode and NDC 69097-219-02 are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.